Products Categories
CAS No.: | 509-67-1 |
---|---|
Name: | PHOLCODINE |
Article Data: | 3 |
Molecular Structure: | |
Formula: | C23H30 N2 O4 |
Molecular Weight: | 398.502 |
Synonyms: | Morphinan-6a-ol, 7,8-didehydro-4,5a-epoxy-17-methyl-3-(2-morpholinoethoxy)-(8CI); Morphine, 3-O-(2-morpholinoethyl)- (7CI); Morphine,O3-(2-morpholinoethyl)- (6CI); 3-[2-(4-Morpholinyl)ethyl]morphine; Biocalyptol;Codylin; Ethnine; Folcodin; Folcodine; Galenphol; Galphol; Glycodine; Hibernyl;Homocodeine; Memine; Morpholinylethylmorphine; Neocodine;O-2-Morpholinoethylmorphine; O3-(2-Morpholinoethyl)morphine; Pectolin;Pholcodine; Pholtex; Tussokon; Weifacodine; b-Morpholinylethylmorphine |
Density: | 1.34g/cm3 |
Melting Point: | 91°C |
Boiling Point: | 577.8°Cat760mmHg |
Flash Point: | 303.2°C |
Safety: | Poison by intraperitoneal and intravenous routes. Moderately toxic by subcutaneous route. When heated to decomposition it emits toxic fumes of NOx. Used as an antitussive agent. See also CODEINE. |
PSA: | 54.40000 |
LogP: | 1.07930 |
Product Name: Pholcodine
Synonyms: (5Alpha,6Alpha)-7,8-Didehydro-4,5-epoxy-17-methyl-3-[2-(4-morpholinyl)ethoxy]morphinan-6-ol ; 3-(2-(4-morpholinyl)ethyl)Morphine ; 3-(2-morpholinoethyl)Morphine ; 3-Morpholylaethylmorphin ; 3-O-(2-morpholinoethyl)-Morphin ; 7,8-Didehydro-4,5-alpha-epoxy-17-methyl-3-(2-morpholinoethoxy)morphinan-6-al ; 7,8-Didehydro-4,5-alpha-epoxy-17-methyl-3-(2-morpholinoethoxy)morphinan-6-alpha-ol ; Beta-morpholinoethylmorphine
CAS: 509-67-1
Molecular Formula: C23H30N2O4
Molecular Weight:398.5
Molecular Struture:
EINECS: 208-102-9
Mol File: 509-67-1.mol
Surface Tension: 63.4 dyne/cm
Density: 1.34 g/cm3
Flash Point: 303.2 °C
Enthalpy of Vaporization: 90.97 kJ/mol
Boiling Point: 577.8 °C at 760 mmHg
Vapour Pressure: 3.44E-14 mmHg at 25°C
Index of Refraction: 1.659
Appearance: Tetrahydro-1,4-oxazinylmethylcodeine (509-67-1) is white or almost white, crystalline powder
Tetrahydro-1,4-oxazinylmethylcodeine (509-67-1) is used for severe dry cough and moderate degree of pain. Newborn and child are easy to tolerate the drug, without causing constipation and digestive disorders.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 400mg/kg (400mg/kg) | Therapie. Vol. 7, Pg. 21, 1952. | |
mouse | LD50 | intravenous | 230mg/kg (230mg/kg) | Therapie. Vol. 7, Pg. 21, 1952. | |
mouse | LD50 | oral | 1gm/kg (1000mg/kg) | Cesko-Slovenska Farmacie. Vol. 12, Pg. 89, 1963. | |
mouse | LD50 | subcutaneous | 540mg/kg (540mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 325, 1958. |
rabbit | LD50 | intravenous | 300mg/kg (300mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 325, 1958. |
Poison by intraperitoneal and intravenous routes. Moderately toxic by subcutaneous route. When heated to decomposition it emits toxic fumes of NOx. Used as an antitussive agent. See also CODEINE.
1.Properties: Tetrahydro-1,4-oxazinylmethylcodeine (509-67-1) is odorless, bitter taste; aqueous react alkaline . soluble in acetone or chloroform,, soluble in water and ether, dissolved in dilute hydrochloric acid.
2.Pharmacological effects: This product has a central antitussive effect similar to codeine phosphate, but also has sedative and analgesic effect, but it's addictive is weaker than codeine phosphate.
3.Consumption usage:Oral: 1 5 ~ 15mg, 1 3 times a day. Maximum dose: 60mg / d.